albuterol has been researched along with losartan potassium in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (75.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fink, GD; Fisher, JW | 1 |
| Beckman, B; Fisher, JW; Gross, DM; Przala, F | 2 |
| Brookins, J; Fisher, JW; Jelkmann, W | 1 |
| Beckman, B; Fisher, JW | 1 |
| Przała, F | 1 |
| Beckman, B; Fisher, JW; Jelkmann, W | 1 |
| Ratcliffe, PJ; Tan, CC | 1 |
| Beckman, B; Brookins, J; Fisher, JW; Ueno, M | 1 |
| Burdowski, A; Fisher, JW; Jubiz, W; Nelson, PK; Radtke, HW | 1 |
| Fisher, JW; Jubiz, W; Radtke, HW; Smith, JB | 1 |
| Canning, CE; Cotes, PM; Lind, T | 1 |
| Bauer, C; Jelkmann, W | 1 |
| Berglund, B; Sundgot-Borgen, J; Wide, L | 1 |
| Achtari Jeanneret, L; Barras-Moret, AC; Carron, P; Deriaz-Chessex, S; Donzé, J; Fournier, Y; Gachoud, D; Moix, PA; Monti, M; Rossier, A; Wilson, P | 1 |
1 trial(s) available for albuterol and losartan potassium
| Article | Year |
|---|---|
Effect of salbutamol, a beta-2-adrenergic agonist, on erythropoietin concentration in healthy males.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Cross-Over Studies; Double-Blind Method; Erythropoiesis; Erythropoietin; Humans; Male; Reference Values | 2002 |
15 other study(ies) available for albuterol and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Stimulation of erythropolesis by beta adrenergic agonists. II. Mechanism of action.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Biological Assay; Bone Marrow; Bone Marrow Cells; Carbon Dioxide; Cells, Cultured; Erythropoiesis; Erythropoietin; Female; Heart Rate; Hydrogen-Ion Concentration; Immune Sera; In Vitro Techniques; Male; Mice; Nephrectomy; Oxygen; Polycythemia; Rabbits | 1977 |
Influence of albuterol on erythropoietin and erythroid stem cell activation.
Topics: Albuterol; Animals; Butoxamine; Erythropoiesis; Erythropoietin; Kidney; Rabbits | 1978 |
Indomethacin blockade of albuterol-induced erythropoietin production in isolated perfused dog kidneys.
Topics: Albuterol; Animals; Dogs; Erythropoietin; Female; Hypoxia; In Vitro Techniques; Indomethacin; Kidney; Perfusion; Pressure; Receptors, Adrenergic, beta | 1979 |
Changes in beta-2 adrenergic receptor sensitivity with maturation of erythroid progenitor cells.
Topics: Albuterol; Animals; Bone Marrow; Butoxamine; Cells, Cultured; Erythropoietin; Hematopoietic Stem Cells; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1979 |
[Effect of stimulation and blockade of beta adrenergic receptors on the production of erythropoietin and erythropoiesis].
Topics: Adrenergic Fibers; Albuterol; Animals; Bone Marrow; Erythropoiesis; Erythropoietin; Haplorhini; Kidney; Mice; Propranolol; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1979 |
Influence of albuterol on erythropoietin production and erythroid progenitor cell activation.
Topics: Albuterol; Animals; Bone Marrow Cells; Butoxamine; Clone Cells; Erythropoietin; Hematopoietic Stem Cells; Propranolol; Rabbits | 1979 |
Enhanced effects of hypoxia on erythropoiesis in rabbits following beta-2 adrenergic activation with albuterol.
Topics: Albuterol; Animals; Drug Interactions; Erythropoiesis; Erythropoietin; Female; Hematocrit; Mice; Oxygen; Rabbits; Time Factors | 1979 |
Rapid oxygen-dependent changes in erythropoietin mRNA in perfused rat kidneys: evidence against mediation by cAMP.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Albuterol; Animals; Bucladesine; Colforsin; Cyclic AMP; Erythropoietin; Hypoxia; In Vitro Techniques; Kidney; Male; Oxygen; Perfusion; Rats; Rats, Inbred Strains; RNA, Messenger | 1992 |
A1 and A2 adenosine receptor regulation of erythropoietin production.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Albuterol; Animals; Erythrocytes; Erythropoietin; Female; Hypoxia; Iron Radioisotopes; Mice; Mice, Inbred ICR; Polycythemia; Receptors, Purinergic; Theophylline | 1988 |
Prostaglandins activation of erythropoietin production and erythroid progenitor cells.
Topics: Albuterol; Animals; Dinoprostone; Dogs; Epoprostenol; Erythropoiesis; Erythropoietin; Female; Hematopoietic Stem Cells; Indomethacin; Kidney; Meclofenamic Acid; Mice; Mice, Inbred ICR; Prostaglandins; Prostaglandins E; Stimulation, Chemical | 1980 |
Albuterol-induced erythropoietin production and prostaglandins release in the isolated perfused dog kidney.
Topics: Albuterol; Animals; Cyclooxygenase Inhibitors; Dogs; Erythropoietin; Female; Kidney; Meclofenamic Acid; Oxygen; Prostaglandins E | 1980 |
Changes in serum immunoreactive erythropoietin during the menstrual cycle and normal pregnancy.
Topics: Adult; Albuterol; Erythropoietin; Female; Humans; Menstruation; Obstetric Labor, Premature; Pregnancy; Radioimmunoassay | 1983 |
beta 2-Adrenergic stimulation of erythropoiesis in busulfan treated mice.
Topics: Albuterol; Anemia, Aplastic; Animals; Busulfan; Erythrocyte Indices; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Iron; Kidney; Mice | 1980 |
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload | 2008 |